MDMA Statement on House MDUFA Hearing
Wednesday, February 15, 2012
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device
Manufacturers Association (MDMA), issued the following statement today
regarding the House Energy and Commerce Subcommittee on Health hearing
entitled "Reauthorization of MDUFA: What it Means for Jobs, Innovation
"MDMA appreciates all of the House Subcommittee's work on the important issue of medical device innovation.
"The user fee reauthorization for medical devices is a
critical component to ensure that the United States doesn't lose our
leadership position in driving patient care and job creation.
"MDMA continues working with FDA, Congress and stakeholders
on our common goals to restore predictability and transparency with the
premarket review process, and to help America’s medical device
innovators continue delivering novel advancements in patient care."